Log In
BCIQ
Print this Print this
 

Adrenergic receptor alpha 2 (ADRA2)

  Manage Alerts
Collapse Summary Pipeline Information
 Pipeline Summary for Products Targeting Adrenergic receptor alpha 2 (ADRA2)

BCIQ
Print ChartPrint this
Marketed, 2 Marketed, 3 Marketed, 1 Marketed, 1 Phase III, 1 Phase II, 1 Phase II, 1 Phase II, 3 Phase II, 1
Phase of DevelopmentPhase IIPhase IIIMarketed
Cardiovascular

-

1

-

Dermatology

1

-

1

Musculoskeletal

-

-

1

Neurology

3

-

3

Ophthalmic

1

-

2

Other

1

-

-




 Products Targeting Adrenergic receptor alpha 2 (ADRA2)
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Summary
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

6

$160,244.2M

$160,041.0M

$200.0M


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury Trial today